64
Participants
Start Date
December 31, 2009
Study Completion Date
April 30, 2010
AZD5847
"Part A - Oral doses given to approximately 6 cohorts of 8 subjects (6 on active and 2 on placebo) on Day 1.~Part B - Oral doses of AZD5847 given to 1 cohort of 8 subjects on Days 1 and 8 in either a fasted state or with a high fat meal"
Placebo to AZD5847
In Part A - Single oral doses of AZD5847placebo given to approximately 6 cohorts of 8 subjects each (6 on active and 2 on placebo) on Day 1
Research Site, Overland Park
Lead Sponsor
Quintiles, Inc.
INDUSTRY
AstraZeneca
INDUSTRY